GNOMGlobal X Genomics & Biotechnology ETF

Grow my money7y track recordRanked #1,590 of 2,966 in this goal

Seeks to provide investment results that correspond generally to the price and yield performance of the Solactive Genomics Index.

By Global X Funds · Launched 2019

Annual Cost

0.50%

#2,578 of 5,568 · average

Fund Size

$56M

#3,476 of 5,568 · mid-size

Return (1Y)Goal

+57.8%

Track Record

7 years

#1,888 of 5,568 · established

Performance

Total-return NAV · USD

Growth of $10,000

$15,934+59.3%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

Global

Cap

Multi cap

Strategy

Index tracking

Sector

Health care

Focus

Biotech & Genomics

Index tracked

Solactive Genomics Index

What it actually holds

By weight

Concentration

Top 10 holdings = 44.0% of fundmoderately concentrated

GUARDANT HEALTH, INC.

5.6%

ILLUMINA, INC.

5.2%

ARROWHEAD PHARMACEUTICALS, INC.

4.9%

NATERA, INC.

4.7%

BIOMARIN PHARMACEUTICAL INC.

4.1%

MODERNA, INC.

4.0%

BIO-TECHNE CORPORATION

3.9%

VERTEX PHARMACEUTICALS INCORPORATED

3.9%

Avidity Biosciences Inc

3.9%

Qiagen N.V.

3.8%

Asset allocation

Stocks

99.9%

Cash

0.1%

By sector

Healthcare

99.7%

Technology

0.3%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

27.3%High

Year-on-year price swings

Max drawdown

-75.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.05Below average

Sortino (3Y)

0.07Moderate downside risk

Where to buy

Listing

Exchange: NASDAQ Global Select Market

Full fund details

Objective: Seeks to provide investment results that correspond generally to the price and yield performance of the Solactive Genomics Index.
Strategy: Invests primarily in securities of the Solactive Genomics Index, which includes companies benefiting from advances in genomic science. The Fund may lend securities and uses a replication strategy to achieve its objective. The Underlying Index is reconstituted semi-annually and weighted by modified free-float capitalization, with a maximum weight of 4% for any company.
Inception date: April 5, 2019
Fund family: Global X Funds